CClinicalTrials.gg
CompletedNCT07454265Updated Mar 6, 2026

Short-Term Broccoli Supplementation and Acute Oxidative Stress Recovery

An interventional study of Broccoli powder and Placebo (no broccoli-derived bioactives) in Healthy Adult Male, sponsored by Lithuanian Sports University. Completed at 1 site in Lithuania. Open to male participants aged 18 Years to 37 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by Lithuanian Sports University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Nov 2024, registered Feb 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Not applicable
Ages
18 Years to 37 Years
Sex
Male
01

Study summary

The study aimed to evaluate the effects of short-term broccoli powder supplementation on metabolically demanding exercise performance, muscle power, and blood lactate recovery. It also investigated broccoli powder-derived sulforaphane bioavailability and its effects in attenuating exercise-induced oxidative stress. Seventeen healthy males (age 23.8 ± 4.9 years, height 182.3 ± 6.1 cm, weight 80.0 ± 12.8 kg), in a double-blind crossover design, three weeks apart, consumed ten standard doses of either broccoli powder or spinach powder as a placebo over a period of 2 weeks. They then performed a maximal progressive cycling task with concomitant analysis of expired gas composition. Plasma malondialdehyde (MDA) level was measured before and 60 min after the completion of the task, and blood lactate and muscle power (counter-movement vertical jump (CMJ) performance) were measured before and up to 60 min after exercise.

Read the detailed description

Intense exercise increases oxygen consumption and mitochondrial respiration, leading to elevated production of reactive oxygen species (ROS). While moderate ROS levels play an essential role in cellular signaling and training adaptation, excessive accumulation may overwhelm antioxidant defenses and promote oxidative damage to lipids, proteins, and nucleic acids. The balance between ROS production and endogenous antioxidant systems is therefore critical during and after strenuous exercise. Traditional antioxidant supplementation has produced inconsistent findings, with some evidence suggesting that high doses of exogenous antioxidants may blunt adaptive signaling. Consequently, attention has shifted toward nutritional strategies that enhance endogenous cytoprotective pathways rather than directly scavenging free radicals.

Broccoli is rich in glucoraphanin, the precursor of sulforaphane (SFN), a bioactive isothiocyanate formed through myrosinase-mediated hydrolysis. SFN activates the Nrf2 signaling pathway, upregulating phase II detoxifying and antioxidant enzymes such as heme oxygenase-1 and NAD(P)H quinone oxidoreductase-1, thereby strengthening intrinsic antioxidant defense mechanisms. Although sulforaphane has demonstrated cytoprotective and anti-inflammatory properties, its effects on exercise-induced oxidative stress in healthy, recreationally active individuals remain insufficiently characterized. The present study examined whether short-term broccoli powder supplementation enriched with myrosinase influences sulforaphane bioavailability, oxidative stress, performance, and recovery following metabolically demanding exercise.

Seventeen healthy young men (23.8 ± 4.9 years) completed a randomized, double-blind, placebo-controlled crossover study with a three-week washout period. Ethical approval was obtained from the Lithuanian Sports University Ethics Committee, and all participants provided written informed consent. Participants maintained habitual diet and physical activity and reported intake of caffeine, alcohol, cruciferous vegetables, and supplements prior to testing.

The intervention consisted of 10 g broccoli powder (99.5% broccoli powder, 0.5% mustard seed powder providing myrosinase; \~320 μg glucoraphanin per dose) mixed with 300 mL beverage. The placebo consisted of spinach powder prepared identically. Ten doses were consumed over 14 days, with the final dose ingested three hours before exercise testing.

Sulforaphane bioavailability was assessed from 24-hour urine collection after the first dose using liquid chromatography-mass spectrometry. The exercise protocol involved an incremental cycling test to voluntary exhaustion starting at 40 W with a ramp increase of 20 W per minute. Respiratory gases and heart rate were continuously measured, and VO₂max was determined as the highest 20-second average achieved, verified by standard physiological criteria.

Countermovement jump height was assessed before exercise and 1, 30, and 60 minutes post-exercise. Capillary blood lactate was measured pre-exercise and during recovery (1-60 minutes). Venous blood samples were collected before and one hour after exercise to determine plasma malondialdehyde concentration as a marker of lipid peroxidation. Data were analyzed using repeated measures ANOVA with statistical significance set at p \< 0.05.

02

Conditions studied

  • Healthy Adult Male

Keywords

  • Sulforaphane
  • Bioavailability
  • Lactate
  • VO₂max
03

In context

Lead sponsor

Lithuanian Sports University is the lead sponsor of 36 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 37 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • males;
  • age:18-37 years;
  • no illnesses or injuries in the month preceding data collection and were engaged in organized physical activity no more than twice per week.

Exclusion criteria

Exclusion Criteria:

  • Non-compliance with the study protocol, illness, or injury during the study period.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Experimental
    male healthy volunteers aged 18-37 years

    Participants completed both conditions in a crossover design with washout. They consumed 10 g broccoli powder (\~320 μg glucoraphanin) or matched spinach placebo for 14 days (10 doses), final dose 3 h pre-test.

    Dietary Supplement: Broccoli powder · Dietary Supplement: Placebo (no broccoli-derived bioactives)

Interventions

  • Dietary supplementBroccoli powder

    The intervention consisted of a single 35-mL scoop of broccoli powder (BrocAffex; 99.5% broccoli powder and 0.5% mustard seed powder), corresponding to 10 g of supplement and delivering 320 μg of glucoraphanin per serving. The supplement was mixed with 300 mL of chocolate oat milk (13 participants) or 300 mL of orange juice (4 participants).

  • Dietary supplementPlacebo (no broccoli-derived bioactives)

    1/2 x 35 ml scoop of dried spinach powder blended with 300 ml of chocolate oat milk (13 participants) or orange juice (4 participants).

06

What researchers measure

Primary outcomes

  1. Sulforaphane, mg/24hours

    Time frame: Urine was collected over a 24-hours period following ingestion of the first supplementation dose in both conditions, and sulforaphane was subsequently extracted and analyzed up to one week after study completion.

  2. Plasma malondialdehyde concentration, nmol/mL

    Time frame: Blood sample was collected before incremental cycling and 1 hour post-test in both conditions and plasma malondialdehyde concentration was subsequently analyzed up to one week after study completion.

  3. Peak power output, Watts

    Time frame: During each experimental condition (at peak exercise during incremental ramp cycling test)

  4. Maximal oxygen uptake, mL/min/kg

    Time frame: During each experimental condition (at peak exercise during incremental ramp cycling test)

Secondary outcomes

  1. Peak heart rate, beats per minute

    Time frame: During each experimental condition (at peak exercise during incremental ramp cycling test)

  2. Blood lactate concentration, mmol/L

    Time frame: Capillary blood lactate was measured before the metabolically demanding exercise task, and then 1 minute, 3 minutes, 5 minutes, 30 minutes and 60 minutes post-exercise in both conditions.

  3. Jump height, cm

    Time frame: Countermovement jump (CMJ) height was measured before (baseline), and then 1 minute, 30 minutes, and 60 minutes after the metabolically demanding exercise task in both conditions.

07

Study locations

1 site
  • Lithuanian Sports University
    Kaunas, Lithuania
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 3, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07454265
Lead sponsor
Lithuanian Sports University
Responsible party
Sponsor
First posted
Mar 6, 2026
Start date
Nov 30, 2024
Primary completion
Jan 1, 2025
Completion
Jan 10, 2025
Last update
Mar 6, 2026

Study contacts

Sigitas Kamandulis, Dr.
principal investigator · Lithuanian Sports University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion